Cargando…
The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol
BACKGROUND: The basal follicle stimulating hormone (FSH)/luteinizing hormone (LH) ratio is a useful predictor of ovarian response. In this study, we investigated whether the FSH/LH ratios during the entire controlled ovarian stimulation (COS) can be used as effective predictors of outcomes in women...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922742/ https://www.ncbi.nlm.nih.gov/pubmed/36793280 http://dx.doi.org/10.3389/fendo.2023.1093954 |
_version_ | 1784887592627470336 |
---|---|
author | Zhao, Shen Xu, Huihui Wu, Xian Xia, Lan Li, Jian Zhang, Dan Zhang, Aijun Xu, Bufang |
author_facet | Zhao, Shen Xu, Huihui Wu, Xian Xia, Lan Li, Jian Zhang, Dan Zhang, Aijun Xu, Bufang |
author_sort | Zhao, Shen |
collection | PubMed |
description | BACKGROUND: The basal follicle stimulating hormone (FSH)/luteinizing hormone (LH) ratio is a useful predictor of ovarian response. In this study, we investigated whether the FSH/LH ratios during the entire controlled ovarian stimulation (COS) can be used as effective predictors of outcomes in women undergoing in vitro fertilization (IVF) treatment using the gonadotropin releasing hormone antagonist (GnRH-ant) protocol. METHODS: A total of 1,681 women undergoing their first GnRH-ant protocol were enrolled in this retrospective cohort study. A Poisson regression model was used to analyze the association between the FSH/LH ratios during COS and embryological outcomes. Receiver operating characteristic analysis was performed to determine the optimal cutoff values for poor responders (≤ 5 oocytes) or poor reproductive potential (≤ 3 available embryos). A nomogram model was constructed to provide a tool for predicting the cycle outcomes of individual IVF treatments. RESULTS: The FSH/LH ratios (at the basal day, stimulation day 6 (SD6) and trigger day) were significantly correlated with the embryological outcomes. The basal FSH/LH ratio was the most reliable predictor of poor responders with a cutoff value of 1.875 (area under the curve (AUC) = 72.3%, P < 0.05), or of poor reproductive potential with a cutoff value of 2.515 (AUC = 66.3%, P < 0.05). The SD6 FSH/LH ratio predicted poor reproductive potential with a cutoff value of 4.14 (AUC = 63.8%, P < 0.05). The trigger day FSH/LH ratio predicted poor responders with a cutoff value of 9.665 (AUC = 63.1%, P < 0.05). The basal FSH/LH ratio, combined with the SD6 and trigger day FSH/LH ratios, slightly increased these AUC values and improved the prediction sensitivity. The nomogram provides a reliable model with which to assess the risk of poor response or poor reproductive potential directly based on the combined indicators. CONCLUSIONS: FSH/LH ratios are useful predictors of poor ovarian response or reproductive potential throughout the entire COS with the GnRH antagonist protocol. Our findings also provide insights into the potential for LH supplementation and regimen adjustment during COS to achieve improved outcomes. |
format | Online Article Text |
id | pubmed-9922742 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99227422023-02-14 The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol Zhao, Shen Xu, Huihui Wu, Xian Xia, Lan Li, Jian Zhang, Dan Zhang, Aijun Xu, Bufang Front Endocrinol (Lausanne) Endocrinology BACKGROUND: The basal follicle stimulating hormone (FSH)/luteinizing hormone (LH) ratio is a useful predictor of ovarian response. In this study, we investigated whether the FSH/LH ratios during the entire controlled ovarian stimulation (COS) can be used as effective predictors of outcomes in women undergoing in vitro fertilization (IVF) treatment using the gonadotropin releasing hormone antagonist (GnRH-ant) protocol. METHODS: A total of 1,681 women undergoing their first GnRH-ant protocol were enrolled in this retrospective cohort study. A Poisson regression model was used to analyze the association between the FSH/LH ratios during COS and embryological outcomes. Receiver operating characteristic analysis was performed to determine the optimal cutoff values for poor responders (≤ 5 oocytes) or poor reproductive potential (≤ 3 available embryos). A nomogram model was constructed to provide a tool for predicting the cycle outcomes of individual IVF treatments. RESULTS: The FSH/LH ratios (at the basal day, stimulation day 6 (SD6) and trigger day) were significantly correlated with the embryological outcomes. The basal FSH/LH ratio was the most reliable predictor of poor responders with a cutoff value of 1.875 (area under the curve (AUC) = 72.3%, P < 0.05), or of poor reproductive potential with a cutoff value of 2.515 (AUC = 66.3%, P < 0.05). The SD6 FSH/LH ratio predicted poor reproductive potential with a cutoff value of 4.14 (AUC = 63.8%, P < 0.05). The trigger day FSH/LH ratio predicted poor responders with a cutoff value of 9.665 (AUC = 63.1%, P < 0.05). The basal FSH/LH ratio, combined with the SD6 and trigger day FSH/LH ratios, slightly increased these AUC values and improved the prediction sensitivity. The nomogram provides a reliable model with which to assess the risk of poor response or poor reproductive potential directly based on the combined indicators. CONCLUSIONS: FSH/LH ratios are useful predictors of poor ovarian response or reproductive potential throughout the entire COS with the GnRH antagonist protocol. Our findings also provide insights into the potential for LH supplementation and regimen adjustment during COS to achieve improved outcomes. Frontiers Media S.A. 2023-01-30 /pmc/articles/PMC9922742/ /pubmed/36793280 http://dx.doi.org/10.3389/fendo.2023.1093954 Text en Copyright © 2023 Zhao, Xu, Wu, Xia, Li, Zhang, Zhang and Xu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Zhao, Shen Xu, Huihui Wu, Xian Xia, Lan Li, Jian Zhang, Dan Zhang, Aijun Xu, Bufang The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol |
title | The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol |
title_full | The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol |
title_fullStr | The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol |
title_full_unstemmed | The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol |
title_short | The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol |
title_sort | serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922742/ https://www.ncbi.nlm.nih.gov/pubmed/36793280 http://dx.doi.org/10.3389/fendo.2023.1093954 |
work_keys_str_mv | AT zhaoshen theserumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol AT xuhuihui theserumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol AT wuxian theserumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol AT xialan theserumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol AT lijian theserumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol AT zhangdan theserumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol AT zhangaijun theserumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol AT xubufang theserumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol AT zhaoshen serumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol AT xuhuihui serumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol AT wuxian serumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol AT xialan serumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol AT lijian serumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol AT zhangdan serumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol AT zhangaijun serumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol AT xubufang serumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol |